1. MicroRNAs as molecular biological markers of benign hyperplasia and prostate cancer differentiation
    Z. M. Akhokhov et al, 2023, Urology Herald CrossRef
  2. miRNAs as Therapeutic Tools and Biomarkers for Prostate Cancer
    Noemi Arrighetti et al, 2021, Pharmaceutics CrossRef
  3. For Physicians Managing Voiding Dysfunction, Improving the Detection Rate of Early Prostate Cancer and Discrimination From Benign Prostatic Hyperplasia, in a Molecular Biomarker Aspects
    Won Tae Kim et al, 2019, International Neurourology Journal CrossRef
  4. miR-221, miR-650 and miR-4534 as diagnostic markers in prostate cancer and their relationship with lymphatic invasion
    Kuyaş Hekımler Öztürk et al, 2022, Turkish Journal of Biochemistry CrossRef
  5. A Radiogenomic Approach for Decoding Molecular Mechanisms Underlying Tumor Progression in Prostate Cancer
    null Fischer et al, 2019, Cancers CrossRef
  6. The Clinical Usefulness of Prostate Cancer Biomarkers: Current and Future Directions
    Donovan McGrowder et al, 2022, Cancer Bioinformatics CrossRef
  7. miR-96-5p, miR-134-5p, miR-181b-5p and miR-200b-3p heterogenous expression in sites of prostate cancer versus benign prostate hyperplasia—archival samples study
    Kacper Pełka et al, 2021, Histochemistry and Cell Biology CrossRef
  8. Analysis of miRNAs in the PSMA-positive fraction of plasma nano-sized extracellular vesicles in patients with prostate cancer
    L. M. Zabegina et al, 2022, Cancer Urology CrossRef
  9. The role of miRNA in the pathogenesis of diseases associated with functional dysregulation of the lacrimal gland
    T.N. Safonova et al, 2023, Vestnik oftal'mologii CrossRef
  10. Recent Advances in the Management of Hormone-Sensitive Oligometastatic Prostate Cancer
    Giulia Marvaso et al, 2022, Cancer Management and Research CrossRef

  11. Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer: A Literature Review


    Christopher J McNally et al, 2020, Cancer Management and Research CrossRef
  12. Exploration of the Value of Combined UA, IL-6, and fPSA/tPSA in the Diagnosis of Prostate Cancer
    Qionghua Tang et al, 2022, Computational and Mathematical Methods in Medicine CrossRef
  13. Exploring miRNA Signature and Other Potential Biomarkers for Oligometastatic Prostate Cancer Characterization: The Biological Challenge behind Clinical Practice. A Narrative Review
    Giulia Corrao et al, 2021, Cancers CrossRef